While Illumina (ILMN +3.9%) has rebounded from the weakness caused by Life Technologies' (LIFE...

|By:, SA News Editor

While Illumina (ILMN +3.9%) has rebounded from the weakness caused by Life Technologies' (LIFE +7.2%) product announcement, smaller rival Complete Genomics' (GNOM -19.9%) bloodletting worsens as the day progresses. On Monday, the company announced it delivered 300 fewer genomes in Q4 than previously expected, news that triggered a downgrade from Oppenheimer.